HALIFAX, NS, Aug. 19, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that it has acquired ownership of, and control over, an additional $246,000 principal amount of Clarke Inc. Convertible Debentures (“Convertible Debentures”) which, if converted, would entitle G2S2 to 17,904 common shares of Clarke Inc. (“Clarke”) and represent 0.12% of the outstanding common shares of Clarke (“Common Shares”). G2S2 acquired the Convertible Debentures on August 18, 2022, through the facilities of the Toronto Stock Exchange at a price of $989.65 per $1,000 of principal (the “Acquisition”).

HALIFAX, NS, Aug. 11, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that its wholly owned subsidiary has disposed of common shares (“Shares”) of Knight Therapeutics Inc. (“Knight”) and no longer holds over 10% of Knight’s outstanding Shares.